Soluções e Reagentes da Farmacopeia dos Estados Unidos (USP)
As soluções e reagentes da Farmacopeia dos Estados Unidos (USP) são cruciais para garantir a segurança, qualidade e eficácia dos produtos farmacêuticos no mercado dos EUA. Esses produtos cumprem os padrões estabelecidos pela USP e são amplamente utilizados no desenvolvimento de medicamentos e no controle de qualidade. Na CymitQuimica, oferecemos uma ampla gama de soluções e reagentes em conformidade com a USP para apoiar a pesquisa e fabricação farmacêutica.
Foram encontrados 7624 produtos de "Soluções e Reagentes da Farmacopeia dos Estados Unidos (USP)"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Paroxetine Related Compound D ((3RS,4RS)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride); cis-paroxetine hydrochloride
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H20FNO3·HClCor e Forma:White Off-White Crystalline PowderPeso molecular:365.83 g/molEpoprostenol Related Compound A (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C20H34O6Cor e Forma:White PowderPeso molecular:370.48Levocetirizine Amide
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C21H26ClN3O2Cor e Forma:White PowderPeso molecular:387.17135Benazepril Related Compound G ((3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine)-1-acetic acid, ethyl ester)
CAS:Lactams, nesoiFórmula:C26H32N2O5Cor e Forma:White Clumpy Crystalline PowderPeso molecular:452.23112rac-Duloxetine-d7 Maleate (N-methyl-3-((naphthalen-1-yl-d7)oxy)-3-(thiophen-2-yl)propan-1-amine, maleate)
Isotopes, except those of hdg 2844; compounds, inorganic or organic, of such isotopes, whether or not chemically defined, nesoiFórmula:C18H12D7NOS·C4H4O4Cor e Forma:Off-White SolidPeso molecular:420.53Spironolactone Related Compound I (S-[17α-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7α-yl]ethanethioate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C24H36O4SCor e Forma:White PowderPeso molecular:420.23343Meso-Zeaxanthin
CAS:Coloring matter of vegetable or animal originFórmula:C40H56O2Cor e Forma:Orange Red Yellow PowderPeso molecular:568.42803Dihydrostreptomycin Sulfate
CAS:Dihydrostreptomycin and its derivatives; salts thereofFórmula:(C21H41N7O12)2·3H2SO4Cor e Forma:White PowderPeso molecular:1166.56264N-Nitroso Racepinephrine Solution (1 mL ) (N-(2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)-N-methylnitrous amide)
CAS:Compounds with other nitrogen function, nesoiFórmula:C9H12N2O4Cor e Forma:Colorless LiquidPeso molecular:212.07971Phenylephrine Bitartrate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C9H13NO2·C4H6O6Cor e Forma:White Off-White PowderPeso molecular:167.09463Dapagliflozin Related Compound A ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C21H25BrO6Cor e Forma:White SolidPeso molecular:453.33 g/molMontelukast for Peak Identification
Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedCor e Forma:White Off-White PowderPrimidone Related Compound C (2-phenyl butyramide)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C10H13NOCor e Forma:White Crystalline PowderPeso molecular:163.09971Oxcarbazepine Related Compound C (Acridin-9(10H)-one)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFórmula:C13H9NOCor e Forma:Yellow Green SolidPeso molecular:195.06841Felbamate Related Compound B (Phenethyl carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C9H11NO2Cor e Forma:White Crystalline PowderPeso molecular:165.07898Etravirine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C20H15BrN6OCor e Forma:White Off-White PowderPeso molecular:434.04907Bis((R)-butyramide) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C8H17N3O2Cor e Forma:White Off-White PowderPeso molecular:187.132084-Nitroimidazoleethanol (2-(4-Nitro-1H-imidazol-1-yl)ethanol)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C5H7N3O3Cor e Forma:White PowderPeso molecular:157.04874Levothyroxine Benzamide (4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzamide)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C13H7I4NO3Cor e Forma:Off-White PowderPeso molecular:732.66048Nonacosane (Nonacosane)
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFórmula:C29H60Cor e Forma:White PowderPeso molecular:408.4695Tacrolimus 8-propyl analog (See USP Certificate for full Chemical Name)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C44H71NO12Cor e Forma:White PowderPeso molecular:805.49763Omeprazole Dihydropyridine (1-(5-Methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H15N3O4Cor e Forma:Off-White PowderPeso molecular:313.10626Tetrahydrozoline Related Compound D (2-(Naphthalen-1-yl)-4,5-dihydro-1H-imidazole hydrochloride)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C13H12N2·HClCor e Forma:Light Yellow PowderPeso molecular:196.100056,6'-Dinicotinic Acid
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C12H8N2O4Cor e Forma:White Off-White Light Yellow PowderPeso molecular:244.04841Travoprost Related Compound A ((Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-{(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl)hept-5-enoic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their deFórmula:C23H29F3O6Cor e Forma:Colorless LiquidPeso molecular:458.19162CHO HCP Protein Disulfide Isomerase Heavy Peptide 2 (50 uL)
Isotopes, except those of hdg 2844; compounds, inorganic or organic, of such isotopes, whether or not chemically defined, nesoiFórmula:C48C6H88N10N2O11Cor e Forma:LiquidPeso molecular:1088.68375Desmethyl Pazopanib Hydrochloride (5-({4-[(2,3-Dimethyl-2H-indazol-6-yl) amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide monohydrochloride)
Sulfonamides, nesoiFórmula:C20H21N7O2S·HClCor e Forma:Off-White PowderPeso molecular:459.12442Leflunomide Related Compound C (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H9F3N2O2Cor e Forma:Yellow White PowderPeso molecular:270.06161AAV8 for Capsid Titer (100 uL)
Human blood; animal blood prepared for therapeutic, prophylatic or diagnostic uses; antisera and other blood fractions, etc. nesoiCor e Forma:Colorless Clear LiquidResidual Solvent Class 1 - 1,1-Dichloroethene
CAS:Other unsaturated chlorinated derivatives of acyclic hydrocarbonsFórmula:C2H2Cl2Cor e Forma:Colorless LiquidPeso molecular:95.95336Loratadine Related Compound B (8-Chloro-5,6-dihydro-11-(N-methylpiperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C20H21ClN2Cor e Forma:White Crystalline PowderPeso molecular:324.13933Dipyridamole
CAS:Drugs containing a pyrimidine ring (whether or not hydrFórmula:C24H40N8O4Cor e Forma:PowderPeso molecular:504.31725Tiotropium Related Compound H ((2RS,3aSR,5RS,6RS,6aRS)-6-Hydroxy-4,4-dimethylhexahydro-2H-2,5-methanofuro[3,2-b]pyrrol-4-ium bromide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C9H16BrNO2Cor e Forma:White PowderPeso molecular:250.14Mexiletine Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFórmula:C11H17NOHClCor e Forma:PowderPeso molecular:215.72Nadolol Related Compound G (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C17H27NO2Cor e Forma:Off-White PowderPeso molecular:277.4Clopidogrel Amide ((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H15ClN2OSCor e Forma:White Off-White SolidPeso molecular:306.05936Diclazuril System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:Off-White Yellow PowderZolmitriptan Related Compound G ((S)-4-(4-Aminobenzyl)oxazolidin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H12N2O2Cor e Forma:Light Brown PowderPeso molecular:192.089883-Amino-2,4,6-triiodobenzoic Acid
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFórmula:C7H4I3NO2Cor e Forma:Light Yellow Amorphous PowderPeso molecular:514.73762Carvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C40H42N4O6Cor e Forma:Off-White Light Brown SolidPeso molecular:674.78Pramipexole Related Compound D ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride)
CAS:Compounds containing a benzothiazole ring-system (whethFórmula:C10H17N3S·2HClCor e Forma:Off-White PowderPeso molecular:283.06767Ethyl Nintedanib (Ethyl (Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate)
CAS:Lactams, nesoiFórmula:C32H35N5O4Peso molecular:553.2689Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H41N7O5Cor e Forma:PowderPeso molecular:627.31692O-Desmethyl Apixaban (1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS:Lactams, nesoiFórmula:C24H23N5O4Cor e Forma:White PowderPeso molecular:445.48Carvedilol System Suitability Mixture (carvedilol spiked with carvedilol related compound F)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderGalantamine Hydrobromide Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderUrea
CAS:Urea, whether or not in aqueous solutionFórmula:CH4N2OCor e Forma:White Powder CrystalsPeso molecular:60.03236Desfluoro Flunarizine Dihydrochloride (1-[(4-Fluorophenyl)-phenylmethyl]-4-(3-phenylprop-2-enyl)piperazine dihydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C26H27FN22·HClPeso molecular:386.21583Nafcillin System Suitability Mixture (This mixture contains nafcillin sodium and ethoxynaphthoic acid)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:Off-White Powder
